Nanyang invests $2.5m in Genetic Solutions

By Graeme O'Neill
Thursday, 17 March, 2005

Sydney venture capital company Nanyang Ventures has injected $2.5 million into Genetic Solutions to help accelerate the Brisbane genetic information-technology company's product development and international marketing initiatives.

Genetic Solutions applies DNA marker technology for the improvement of livestock and aquaculture species.

Its GeneSTAR diagnostic tests for meat tenderness are widely used by beef cattle breeders in Australia and North America, and its SureTRAK system currently allows about 15 per cent of Australia's beef production to be traced from supermarket shelves back through the production chain.

Genetic Solutions managing director Gerard Davis said the investment, from Nanyang's Innovation Funds, would allow his company to move into new markets in Europe and Asia.

It will also allow the company to diversify its DNA-marker products into other livestock, and accelerate product development for a more rapid rollout of new diagnostic tests.

Genetic Solutions chairman Mel Bridges said the injection of funds cleared the path for a rapid growth trajectory.

Nanyang Ventures invests with the aim of building listable companies. Company spokesman John Mulquiney said the Genetic Solutions management team had been successful at commercialising the company's technology.

Related News

Noxopharm says paper reveals science behind its immune system platform

Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...

Neurosensing/neurostimulation implants session to be held on Monday

On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...

argenx and Monash University partner against autoimmune diseases

To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd